Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
20.11.23
/
50%
€96.00
Target price
20.11.24
€146.38
Performance (%)
76.41%
End price
21.11.24
€169.35
Summary
This prediction ended on 21.11.24 with a price of €169.35. With a performance of 76.41% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 18.919% | 18.919% | 81.018% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $160.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten